BETR Q1 2026 Earnings Wide EPS Miss Sends Shares Lower SIRI Q1 2026 Earnings EPS Surpasses Estimates Yet Stock Declines PLBY Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Climbs 391 Corcept Therapeutics CORT Q1 2026 Earnings Severe Earnings Miss Overshadows Operational Developments CRISPR Therapeutics Q1 2026 Earnings Slight EPS Miss as Clinical Pipeline Progresses BNR Q3 2022 Earnings EPS Surpasses Estimates Despite Revenue Discretion and Stock Decline